RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
82 hedge funds and large institutions have $391M invested in Revance Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 18 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
82
Holding in Top 10
2
Calls
$855K
Puts
$268K
Top Buyers
| 1 | +$9.35M | |
| 2 | +$7.28M | |
| 3 | +$4.06M | |
| 4 |
PC
PointState Capital
New York
|
+$3.4M |
| 5 |
Bank of New York Mellon
New York
|
+$2.07M |
Top Sellers
| 1 | -$2.21M | |
| 2 | -$2.05M | |
| 3 | -$1.92M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$1.65M |
| 5 |
Millennium Management
New York
|
-$1.63M |